At a glance
ClinicalIndex Comparison RecordN/ACompleted· 124 enrolled
Drug / intervention
Mitral Valve Repairdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
In Brief
A clinical study evaluating Mitral Valve Repair for Mitral Valve Regurgitation. Completed, enrolled 124 participants across 17 sites in 7 countries.
Detailed Summary
The purpose of this study is to assess the safety, performance and clinical outcomes of the Edwards PASCAL Transcatheter Mitral Valve Repair (TMVr) System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMitral Valve Regurgitation
CountriesAustralia, Canada, Germany, Greece, Italy, Switzerland, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartJun 2017
Primary CompletionJul 2020
Study CompletionMay 2025
TodayJul 2026
First PostedMay 31, 2017
Enrollment StartJun 27, 2017
Primary CompletionJul 30, 2020
Study CompletionMay 27, 2025
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 9.1 years ago
Interventions
Mitral Valve Repairdevice
Minimal Invasive Transcatheter Mitral Valve Repair